Skip to main content Skip to search Skip to main navigation

Can GMP Data be in the Cloud?

7 min. reading time | by Thomas Peither
Published in LOGFILE 2/2024

The pace of digitalisation is accelerating. And it is presenting us with new opportunities at ever shorter intervals. This means that all GMP professionals need to be informed and make risk-based decisions! This also applies to data storage in the cloud. What are the opportunities and risks? Which cloud and service models exist? 
In today’s feature, GMP expert Thomas Peither summarises the key points.

What is cloud computing?

Cloud computing is not a new technology, but a new way of providing resources for data processing.

Cloud computing services range from data storage and processing to software such as email processing. Such services are non-binding and available on demand.

As we are in a time of austerity, many companies are opting for predictable running costs rather than long-term, uncertain investments. With rapid innovation cycles and high costs, this new business model for data processing found fertile ground and is expanding worldwide.

The German Federal Office for Information Security (BSI) defines cloud computing as follows:

"Cloud computing is a model that makes it possible,

  • on demand,
  • anytime, anywhere and conveniently via a network
  • to access a shared pool of configurable computing resources (e.g. networks, servers, storage systems, applications and services),
  • that can be rapidly provisioned and with minimal management effort or service provider interaction“.

It is useful to initially think of a "cloud" first as a data centre, i.e. a third-party data centre. However, a regulated company has the same responsibility for the compliant operation of computerised systems as it does in its own data centre – only now the infrastructure and data are located elsewhere.

In principle, the control or management of the data is entrusted to the cloud provider, while the responsibility remains with the pharmaceutical manufacturer. From the perspective of a GMP regulated company, this immediately raises questions about

  • data security,
  • data availability and
  • data integrity.

Cloud models

The type of software provision distinguishes between different types of cloud.

Common models are:

  • Public Cloud
  • Community Cloud
  • Private Cloud
  • Virtual Private Cloud
  • Hybrid Cloud

Service models

Then there is the type of service model, and this is where things get a bit complicated. Let me just pick out the most common acronyms:

  • IaaS – Infrastructure as a Service

This is a computer infrastructure that is provided and managed via the Internet. Companies utilise the computing capacities and pay for the use of the computing power.

  • PaaS – Platform as a Service

Here, the company rents a complete operating system or a development environment. The customer is responsible for the applications running on it.

  • SaaS – Software as a Service

Finally, the user company is only responsible for the customer-specific data and access. Many people are familiar with this from SAP or accounting programmes. GMP Compliance Adviser is also a SaaS.

You can set favourites in the GMP Compliance Adviser for which we as a publisher are not responsible. OurGMP:READY e-learnings are also included in this category.

As you can see, things were different 10 years ago, and software often even had to be installed on a PC in the company. Today and in the future, we will only access the resources provided. This is also called division of labour – why should a pharmaceutical company be so deeply involved in IT issues when its core competency is drug production?

And of course the GMP Compliance Adviser does not run on a server in our basement, but in a cloud environment. This is not only more secure, but also more stable and less prone to downtime.

The word "more secure" may have raised an eyebrow. That’s OK, because we also wanted to look at the opportunities and risks of using the cloud.

Let's start with the opportunities:

Cloud-based services are used extensively in private areas (social media, online shopping) and are widely used in retail, banking, entertainment, etc.

These are seen as advantages:

  • Cost savings
  • Speed
  • Flexibility
  • Security

On the other hand, there are disadvantages that can arise in unfavourable cases:

  • Penalties
  • Downtime
  • Loss of sales
  • Damage to reputation
  • Loss of customer confidence

The Cloud Security Alliance (CSA) regularly collects, analyses and summarises the potential risks of using the cloud. In 2022, the report "Top Threats to Cloud Computing - Pandemic Eleven" was published.

I encourage you to read this list, as it will give you an idea of the range of issues, from insecure security architectures to hacking to steal data.

However, it is important to remember that when companies decide to keep all applications and data in-house, most of these risks are still present and need to be managed with in-house expertise.

Professional cloud services already cover these risks.

Expertise is always a key factor in the decision to outsource or insource. How much does external or internal expertise cost? The premise of division of labour also applies here.


This article is a shortened and translated excerpt from the 39th episode of our German GMP & TEA webcast.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Thomas Peither
Thomas Peither

You may also be interested in the following articles:

News: EMA

EMA Clarifies Batch Numbering for Parallel-Traded Medicines

EMA updated its GMP/GDP Q&A collection by revising the answer to Question 4 concerning Chapter 5 of the EU GMP Guide. It explains which batch numbers should appear on the packaging of parallel-traded medicines.

Read more
Question of the Week | GMP-Verlag

Why is it Important to use Consistent Microbiological Air Monitoring Methods in Pharmaceutical Cleanrooms?

Here's the answer:
Read more
Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Robust PDE reports form the basis of risk-based cleaning validation. This article highlights common deficiencies identified during GMP inspections and explains how they can be avoided.

Read more
News: Europe

EDQM: New Working Party on 3D-printed Medicinal Products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT